Saved content diff

Before

This page announces administrative measures taken by Tokyo and Osaka against wholesale pharmaceutical distributors regarding counterfeit C-type hepatitis treatment drug "Harvoni Combination Tablets." On March 13, 2017, Tokyo issued improvement orders to five companies: Yell Pharmaceutical, Daiko Pharmaceutical, Takayo Pharmaceutical, Fuji Pharmaceutical, and Nogawa Pharmaceutical. Osaka issued an order to Global Net Ells. All orders were based on the Pharmaceutical Affairs Law Article 72-4, Paragraph 1, to ensure product quality, efficacy, and safety.

After

This page announces administrative dispositions issued by Tokyo and Osaka prefectures against wholesale pharmaceutical distributors for violations of the Pharmaceutical Affairs Law. The action was taken following the discovery of counterfeit Harvoni tablets used for hepatitis C treatment. On March 13, 2017, Tokyo imposed improvement orders on five companies: Yell Pharmacy, Daiko Pharmacy, Takayo Pharmacy, Fuji Pharmacy, and Nogawa Pharmacy. Osaka issued an improvement order to Global Net Elz Corporation.